Watchlist Price Alert

Johnson & Johnson (JNJ)

NYSE: JNJ · Real-Time Price · USD

152.56

-0.62 (-0.40%)

At close: May 22, 2025, 3:59 PM

152.62

0.04%

After-hours: May 22, 2025, 07:43 PM EDT

-0.40% (1D)

Bid	152.13
Market Cap	367.07B
Revenue (ttm)	89.33B
Net Income (ttm)	21.81B
EPS (ttm)	8.99
PE Ratio (ttm)	16.97
Forward PE	13.84
Analyst	Hold

Ask	153.11
Volume	4,135,067
Avg. Volume (20D)	9,678,867
Open	152.65
Previous Close	153.18
Day's Range	151.37 - 153.48
52-Week Range	140.68 - 169.99
Beta	0.41

About JNJ

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol JNJ

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for JNJ stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 week ago

-3.7%

Johnson & Johnson shares are trading lower after L... Unlock content with Pro Subscription

1 month ago

-7.59%

Johnson & Johnson shares are trading lower after a Federal Judge rejected the company's subsidiary Red River Talc's request to approve its prepackaged bankruptcy plan.

News

19 hours ago · zacks.com

Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors

In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $152.51, denoting a -0.44% change from the preceding trading day.

16 hours ago · zacks.com

JNJ Down 6% in 3 Months: How to Play the Stock Amid Various Challenges

J&J's JNJ stock has declined 6.4% in the past three months. J&J faces several challenges, including slowing sales in the MedTech segment, loss of exclusivity of its blockbuster drug, Stelara, and unce...

1 day ago · businesswire.com

Johnson & Johnson to Participate in the Bernstein's 41st Annual Strategic Decisions Conference

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the Bernstein's 41st Annual Strategic Decisions Conference on Wednesday, May 28th, 2025. Management will participate...

1 day ago · zacks.com

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

2 days ago · seekingalpha.com

Johnson & Johnson (JNJ) RBC Capital Markets Global Healthcare Conference

Johnson & Johnson (NYSE:JNJ ) RBC Capital Markets Global Healthcare Conference May 20, 2025 1:35 PM ET Corporate Participants Joe Wolk - EVP, Chief Financial Officer Conference Call Participants Shagu...

3 days ago · businesswire.com

Dean Omar Branham Shirley Recognized Twice Among ALM's 2024 Top 100 Verdicts

DALLAS--(BUSINESS WIRE)--National plaintiffs firm Dean Omar Branham Shirley, LLP, has been recognized by ALM and Law.com for securing two of the largest jury verdicts of 2024. Both cases involved clai...

3 days ago · seekingalpha.com

Moody's U.S. Debt Downgrade: Stocks Poised To Benefit

Corporations play a vital and often benevolent role in capitalist societies, supporting economic growth and innovation with more conservative balance sheets than their governments. Microsoft, Apple an...

3 days ago · 247wallst.com

The Only 5 ETFs You Need to Build Wealth for Retirement

Dividend stocks are a foundational building block for creating a retirement portfolio, offering a reliable income stream and potential for capital appreciation.

4 days ago · businesswire.com

Statement On $147M Verdict for AMDR Member Innovative Health Against Johnson & Johnson's Biosense Webster Medical Technology Unit

WASHINGTON & BERLIN--(BUSINESS WIRE)--Association of Medical Device Reprocessors issued the following statement: Friday's unanimous verdict by a federal jury in Santa Ana, California for Innovative He...

5 days ago · fool.com

3 Magnificent Stocks That Are Passive Income Machines

Make money without even trying: That's what passive income is all about. But good investment alternatives are required to make this "easy" money.

Load More News